Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma

Wild-type p53-induced phosphatase (Wip1 or PPM1D) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of Wip1 in RCC remains unclear. The present study investigated its abnormal expression and dysfunctions in clear cell renal cell carcinoma (ccRCC) in vitro. With the combination of immunohistochemistry, western blotting, immunofluorescence, qRT-PCR, and cell proliferation, migration and invasion assays, we found that levels of Wip1 mRNA and protein were dramatically increased in human ccRCC tissues (P<0.001 for both), and upregulation of Wip1 was significantly associated with depth of invasion (P<0.001), Distant metastasis (P = 0.001), lymph node status (P<0.001) and Fuhrman grade (P<0.001). Wip1 knockdown inhibited the proliferation, migration and invasion of 786-O and RLC-310 cells, whereas Wip1 overexpression promoted the growth and aggressive phenotype of 786-O and RLC-310 cells in vitro. The uni- and multivariate analyses indicated that expression of Wip1 was an independent predictor for survival of ccRCC patients (P = 0.003, P = 0.027 respectively). Wip1- negative patients had a higher tumor-free/overall survival rate than patients with high Wip1 expression (P = 0.001, P = 0.002 respectively). Overexpression of Wip1 is useful in the prediction of survival in ccRCC patients.

[1]  D. Lane,et al.  Phosphatase WIP1 regulates adult neurogenesis and WNT signaling during aging. , 2014, The Journal of clinical investigation.

[2]  X. Zu,et al.  Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma , 2014, Tumor Biology.

[3]  Fuqing Zeng,et al.  Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma , 2014, PloS one.

[4]  Guogui Sun,et al.  Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance , 2014, Tumor Biology.

[5]  Stefan M. Pfister,et al.  The WIP1 Oncogene Promotes Progression and Invasion of Aggressive Medulloblastoma Variants , 2014, Oncogene.

[6]  E. Appella,et al.  Genetic variants and mutations of PPM1D control the response to DNA damage , 2013, Cell cycle.

[7]  Yi Wang,et al.  Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma. , 2013, Acta histochemica.

[8]  W. Jiao,et al.  Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway , 2013, PloS one.

[9]  W. Nishio,et al.  Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival , 2011, Cancer science.

[10]  Yolanda F. Darlington,et al.  Dephosphorylation of γ-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control , 2010, Cell cycle.

[11]  R. Medema,et al.  Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition , 2010, Oncogene.

[12]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[13]  M. Wirth,et al.  Advances in renal cell carcinoma treatment , 2010, Therapeutic advances in urology.

[14]  Yolanda F. Darlington,et al.  Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair* , 2010, The Journal of Biological Chemistry.

[15]  Marketa Zvelebil,et al.  PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas , 2009, Clinical Cancer Research.

[16]  E. Appella,et al.  Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. , 2007, Cell stem cell.

[17]  Marie-Claude Marsolier-Kergoat,et al.  The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase , 2007, Oncogene.

[18]  L. Donehower,et al.  Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice , 2006, Molecular carcinogenesis.

[19]  N. Onishi,et al.  Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.

[20]  L. Donehower,et al.  Reversal of the ATM/ATR-Mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D , 2005, Cell cycle.

[21]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[22]  L. Donehower,et al.  The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. , 2000, Genomics.

[23]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Wang,et al.  Expression of Wip1 in Kidney Carcinoma and its Correlation with Tumor Metastasis and Clinical Significance , 2014, Pathology & Oncology Research.

[25]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.